Michael Law

Mike

Faculty, Centre for Health Services and Policy Research
Canada Research Chair in Access to Medicines
Associate Professor, UBC School of Population and Public Health

michael.law@ubc.ca
@MikeLawUBC
(604) 822-3514


Profile

Dr. Michael Law holds the Canada Research Chair in Access to Medicines, and is an Associate Professor in the Centre for Health Services and Policy Research, School of Population and Public Health, at the University of British Columbia.

Michael’s research program focuses on pharmaceutical policy. His work focuses on access to and the use of prescription drugs, including the affordability of prescription drugs, private drug insurance, generic drug pricing, and the impact of pharmacist prescribing. His research program has attracted more than $2.5 million in research funding, including 4 operating grants from CIHR as principal investigator.

He has been published in leading medical journals, including BMJ, Archives of Internal Medicine, and CMAJ. This work has been featured in news media such as New Scientist, Forbes, the Globe & Mail, and USA Today. He has also authored commentaries that have appeared in the Toronto Star and Vancouver Sun. His research has had a major impact on generic drug pricing in Canada, leading to policy changes that have saved governments the country more than $100 million every year.

Since his appointment at UBC he has received several notable awards, including a Distinguished Achievement Award from the UBC Faculty of Medicine (2012), the Labelle Lectureship at McMaster University, the 2011 Paper of the Year Award from the Canadian Institute for Health Services and Policy Research, a Canadian Institutes of Health Research New Investigator Award, and a Michael Smith Foundation for Health Research Scholar Award.

In 2015, he taught one of UBC’s first edX.org Professional Education courses on Interrupted Time Series Analysis.

Prior to joining UBC, he completed a PhD in Health Policy at Harvard University and a post-doctoral fellowship at Harvard Medical School, where he trained in research methods and statistics. He has also completed an MSc from the London School of Economics, and worked as a research associate at the University of Auckland, New Zealand.

Education

PhD, Health Policy, Harvard University, 2008
MSc, Health Population and Society, London School of Economics, 2002
BA&Sc, Arts & Sciences Program, McMaster University, 2001

Research Interests

  • Pharmaceutical policy
  • Direct-to-consumer advertising of prescription drugs
  • Medication adherence and health outcomes

Current Projects

  • Cost-related nonadherence to prescription drugs: A multi-method study
  • Impact of physician detailing and sampling for generic atorvastatin

Affiliations and Awards

  • Career Investigator Scholar Award, Michael Smith Foundation for Health Research, 2012-2020
  • New Investigator Award, CIHR, 2010-2015

Current Graduate Students

  • Talshyn Bolatova, MSc Student, School of Population and Public Health
  • Fiona Chan, MSc Student, School of Population and Public Health
  • Celestin Hategeka, PhD Student, School of Population and Public Health
  • Harriet Ho, MSc Student, School of Population and Public Health
  • Rachel McKay, PhD Student, School of Population and Public Health
  • Richard Musoke, PhD Student, School of Population and Public Health
  • Marie Paul Nisingizwe, PhD Student, School of Population and Public Health
  • Hinda Ruton, PhD Student, School of Population and Public Health
  • Seraphine Zeitouny, MSc Student, School of Population and Public Health

Currently Recruiting Graduate Students Interested in

  • Pharmaceutical policy
  • Access to medicines
  • Observational study design

Courses Currently Taught


Recent Publications

Lavergne MR, Hedden L, Law M, McGrail K, Ahuja M, Barer M. The impact of the 2008/2009 financial crisis on specialist physician activity in Canada. Health Econ. 2018 Jun 19. [Epub ahead of print] Read more

Musabyimana A, Ruton H, Gaju E, Berhe A, Grépin KA, Ngenzi J, Nzabonimana E, Hategeka C, Law MR. Assessing the perspectives of users and beneficiaries of a community health worker mHealth tracking system for mothers and children in Rwanda. PLoS One. 2018 Jun 7;13(6):e0198725. Read more

Innes G, McRae A, Grafstein E, Law M, Teichman JMH, Weber B, Carlson K, Boyda H, Andruchow J. Variability of renal colic management and outcomes in two Canadian cities. CJEM. 2018 Apr 4:1-11. [Epub ahead of print] Read more

Law M, Kolhatkar A. The Nanos Survey on Drug Affordability is Flawed. Here’s Why. Vancouver (BC): UBC Centre for Health Services and Policy Research; Mar 6, 2018. Read more

Innes GD, Scheuermeyer FX, Marsden J, Sing CK, Kalla D, Stenstrom R, Law M, Grafstein E. Impact of physician payment mechanism on emergency department operational performance. CJEM. 2018 Mar;20(2):183-190.Read more

Abimpaye M, Kirk CM, Iyer HS, Gupta N, Remera E, Mugwaneza P, Law MR. The impact of "Option B" on HIV transmission from mother to child in Rwanda: An interrupted time series analysis. PLoS One. 2018 Feb 16;13(2):e0192910. Read more

Al Baz M, Law MR, Saadeh R. Antibiotics use among Palestine refugees attending UNRWA primary health care centers in Jordan - A cross-sectional study. Travel Med Infect Dis. 2018 Feb 16. [Epub ahead of print] Read more

Law MR, Cheng L, Kolhatkar A, Goldsmith LJ, Morgan SG, Holbrook AM, Dhalla IA. The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey. CMAJ Open. 2018 Feb 5;6(1):E63-E70. Read more

Hedden L, Lavergne MR, McGrail KM, Law MR, Cheng L, Ahuja MA, Barer ML. Patterns of physician retirement and pre-retirement activity: a population-based cohort study. CMAJ. 2017 Dec 11;189(49):E1517-E1523. Read more

Skeldon SC, Cheng L, Morgan SG, Detsky AS, Goldenberg SL, Law MR. Erectile Dysfunction Medications and Treatment for Cardiometabolic Risk Factors: A Pharmacoepidemiologic Study. J Sex Med. 2017 Dec;14(12):1597-1605. Read more

Worthington HC, Cheng L, Majumdar SR, Morgan SG, Raymond CB, Soumerai SB, Law MR. The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis. Implement Sci. 2017 Nov 25;12(1):141. Read more

Lavergne MR, Law MR, Peterson S, Garrison S, Hurley J, Cheng L, McGrail K. Effect of incentive payments on chronic disease management and health services use in British Columbia, Canada: Interrupted time series analysis. Health Policy. 2017 Nov 10. [Epub ahead of print] Read more

Hedden L, Barer M, McGrail K, Law M, Bourgeault I. In British Columbia, the supply of primary care physicians grew, but their rate of clinical activity declined. Health Aff (Millwood). 2017 Nov;36(11):1904-1911. Read more

Goldsmith LJ, Kolhatkar A, Popowich D, Holbrook AM, Morgan SG, Law MR. Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application. Soc Sci Med. 2017 Oct 9;194:51-59. Read more

Ngambi PG, Kalungia AC, Law MR, Kalemeera F, Truter I, Godman B, Munkombwe D. Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):459-467. Read more

Older publications